Palliative care management of a child with juvenile onset Huntington's disease

Nicola King1

  • 1Ellenor Foundation, Adj Livingstone Hospital, Dartford Kent DA1 1SA. nicky.king@ellenorfoundation.org

Insights

This case report details palliative care for a 13-year-old with juvenile onset Huntington's disease. It highlights symptom management and ethical considerations in pediatric neurodegenerative terminal care.

Area of Science:

  • Pediatric Palliative Care
  • Neurodegenerative Disorders
  • Huntington's Disease

Background:

  • Juvenile onset Huntington's disease is a rare, life-limiting neurodegenerative condition.
  • Pediatric palliative care services are increasingly available in the UK.
  • Children's hospices provide specialized care for life-limiting conditions.

Observation:

  • A 13-year-old girl with juvenile onset Huntington's disease received palliative care in a UK children's hospice.
  • The case report documents her disease progression and symptom management.
  • Specific medications and interventions for symptom control in her final 10 days are detailed.

Findings:

  • Effective symptom control is crucial for children with neurodegenerative disorders.
  • Palliative care in hospices addresses the complex needs of dying children and their families.
  • Ethical challenges in caring for children with degenerative disorders were explored.

Implications:

  • Findings are relevant to managing other pediatric neurodegenerative conditions.
  • Children's hospices play a vital role in end-of-life care for children.
  • This case underscores the importance of specialized pediatric palliative care and symptom management.

Related Concept Videos

Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
Continuing Care01:25

Continuing Care

Continuing care describes the variety of health, personal, and social services provided over a prolonged period. The need for continuing care is increasing because people are living longer. Many people do not have families or others to care for them. Continuing care is mainly for patients who are disabled, functionally dependent, or suffering from a terminal disease. It is available within institutional settings or in homes. Examples include nursing centers or facilities, assisted living,...
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
Pharmaceutical Poisoning: Treatment Strategies01:26

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...